Proteinase 3 as a marker of clinical severity in bronchiectasis: Data from the EMBARC-BRIDGE studyEmma Johnson, James D. Chalmers, Anthony De Soyza et al.|Unknown|2023Cited by 2
Highlights of the ERS Lung Science Conference and Sleep and Breathing Conference 2021 and the new ECMC membersAmanda Goodwin, Joana Cruz, Dilek Karadoğan et al.|Breathe|2021Cited by 0
Treatment with the dipeptidyl peptidase-1 inhibitor brensocatib increases the antimicrobial peptide secretory leukocyte peptidase inhibitor (SLPI) in patients with bronchiectasis: results from the WILLOW trialLídia Perea, James D. Chalmers, Emma Johnson et al.|Unknown|2023Cited by 0